Figure 2 | Scientific Reports

Figure 2

From: Therapeutic potential of fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes as a haemostatic adjuvant for post-cardiopulmonary bypass coagulopathy

Figure 2

Changes in CBC, coagulation function, and platelet function. (A) White blood cell (WBC) count (cells/μL). (B) Haemoglobin (Hb) concentration (g/dL). (C) Platelet count (× 103 cells/μL). (D) Coagulation function test using the Sonoclot coagulation analyser recorded as activated clotting time (s). (E) Platelet function test using the Multiplate analyser assessed as the collagen test (AUC). Data represent mean ± standard deviation from five mice in the PPP and H12-ADP-liposome/PPP groups and from eight mice in PRP and H12-ADP-liposome/PRP groups. PPP, platelet-poor plasma; PRP, platelet-rich plasma.

Back to article page